AKT1 and cardiac hypertrophy: Activation of the AKT signalling pathway enhances the transcriptional activity of NF‐κB, whereas inhibition of AKT disrupts NF‐κB activity, suggesting that co‐treatment of SE and harmine might exert a synergistic effect against cardiac hypertrophy.10, 11, 12, 13